Skip to main content

Table 1 Characteristics of study participants (n = 1760), by case-control status

From: Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study

Characteristica

Case

Control

All

p-valueb

N (%)

N (%)

N (%)

All

902 (100)

858 (100)

1760 (100)

 

Age at baseline enrollment (years)

   

0.51

 20–39

114 (13)

89 (10)

203 (12)

 

 40–44

121 (13)

125 (15)

246 (14)

 

 45–49

204 (23)

186 (22)

390 (22)

 

 50–54

196 (22)

198 (23)

394 (22)

 

 55–59

152 (17)

135 (16)

287 (16)

 

 60–80

115 (13)

125 (15)

240 (14)

 

Age at blood draw (years)

   

0.35

 40–49

38 (4)

30 (3)

68 (4)

 

 50–59

127 (14)

108 (13)

235 (13)

 

 60–69

362 (40)

369 (43)

731 (42)

 

 70–79

316 (35)

281 (33)

597 (34)

 

 ≥ 80

59 (7)

70 (8)

129 (7)

 

Race/Ethnicity

   

0.40

 White

812 (90)

763 (89)

1575 (89)

 

 Black

14 (2)

7 (1)

21 (1)

 

 Hispanic

24 (3)

32 (4)

56 (3)

 

 Asian/Pacific Islander

29 (3)

32 (4)

61 (3)

 

 Other

23 (3)

24 (3)

47 (3)

 

Region of Residence (CCR region)

   

0.01

 1:Santa Clara Region

82 (9)

83 (10)

165 (9)

 

 2:Central Region

99 (11)

95 (11)

194 (11)

 

 3:Sacramento Region

110 (12)

134 (16)

244 (14)

 

 4:Tri-County Region

65 (7)

62 (7)

127 (7)

 

 5: Inland Empire Region

42 (5)

25 (3)

67 (4)

 

 6:North Region

68 (8)

44 (5)

112 (6)

 

 7:Imperial and San Diego Region

60 (7)

48 (6)

108 (6)

 

 8:Bay Area Region

118 (13)

99 (12)

217 (12)

 

 9:Los Angeles County

173 (19)

148 (17)

321 (18)

 

 10:Orange County

85 (9)

120 (14)

205 (12)

 

Smoking pack-years

   

0.03

 Never smoker

580 (64)

573 (67)

1153 (66)

 

 ≤ 10

156 (17)

153 (18)

309 (18)

 

 11–20

47 (5)

60 (7)

107 (6)

 

 21–30

45 (5)

23 (3)

68 (4)

 

 ≥ 31

42 (5)

27 (3)

69 (4)

 

 Unknown

32 (4)

22 (3)

54 (3)

 

BMI at baseline (kg/m2)

   

0.01

 16.0–24.9

496 (55)

519 (60)

1015 (58)

 

 25.0–29.9

236 (26)

203 (24)

439 (25)

 

 30.0–53.3

153 (17)

110 (13)

263 (15)

 

 Unknown

17 (2)

26 (3)

43 (2)

 

Weight change (Q5-baseline questionnaire)

   

0.08

 Lost weight

161 (18)

133 (16)

294 (17)

 

 No change (+/−5lbs)

201 (22)

235 (27)

436 (25)

 

 Gained weight

346 (38)

317 (37)

663 (38)

 

 Unknown

194 (22)

173 (20)

367 (21)

 

Alcohol consumption (g/day)

   

0.82

 None

278 (31)

250 (29)

528 (30)

 

 < 20

514 (57)

507 (59)

1021 (58)

 

 ≥ 20

74 (8)

66 (8)

140 (8)

 

 Unknown

36 (4)

35 (4)

71 (4)

 

Physical activity (hours/week)

   

0.20

 < 0.50

74 (8)

51 (6)

125 (7)

 

 0.50–3.99

460 (51)

438 (51)

898 (51)

 

 ≥ 4.00

367 (41)

366 (43)

733 (42)

 

 Unknown

1 (0)

3 (0)

4 (0)

 

Family history of breast cancer

   

0.01

 No

728 (81)

737 (86)

1465 (83)

 

 Yes

136 (15)

96 (11)

232 (13)

 

 Unknown

38 (4)

25 (3)

63 (4)

 

Age at menarche (years)

   

0.39

 ≤ 11

227 (25)

189 (22)

416 (24)

 

 12–13

500 (55)

484 (56)

984 (56)

 

 ≥ 14

166 (18)

174 (20)

340 (19)

 

 Unknown/Never

9 (1)

11 (1)

20 (1)

 

Age at first full-term pregnancy (years)

   

0.01

 No full-term pregnancy

233 (26)

186 (22)

419 (24)

 

 ≤ 24

209 (23)

250 (29)

459 (26)

 

 25–29

257 (28)

257 (30)

514 (29)

 

 ≥ 30

193 (21)

151 (18)

344 (20)

 

 Unknown

10 (1)

14 (2)

24 (1)

 

Breast feeding history (months)

   

0.26

 Never pregnant

173 (19)

132 (15)

305 (17)

 

 Pregnancy, but no live birth

58 (6)

53 (6)

111 (6)

 

 0

117 (13)

125 (15)

242 (14)

 

 > 0 and < 6

152 (17)

130 (15)

282 (16)

 

 6–11

121 (13)

132 (15)

253 (14)

 

 ≥ 12

269 (30)

270 (31)

539 (31)

 

 Unknown

12 (1)

16 (2)

28 (2)

 

Menopausal status at time of blood draw

   

0.10

 Pre/Peri-menopausal

43 (5)

59 (7)

102 (6)

 

 Postmenopausal

859 (95)

798 (93)

1657 (94)

 

 Unknown

0 (0)

1 (0)

1 (0)

 

HT use at blood drawc

   

0.06

 Never used and postmenopausal

288 (32)

237 (28)

525 (30)

 

 Ever used and postmenopausal

571 (63)

561 (65)

1132 (64)

 

 Pre/Peri-menopausal

43 (5)

59 (7)

102 (6)

 

 Unknown

0 (0)

1 (0)

1 (0)

 

HT use at baseline

   

0.34

 Never used

64 (7)

68 (8)

132 (8)

 

 Past HT use

29 (3)

37 (4)

66 (4)

 

 Current estrogen use

130 (14)

143 (17)

273 (16)

 

 Current estrogen and progesterone use

240 (27)

199 (23)

439 (25)

 

 Progesterone use only

6 (1)

10 (1)

16 (1)

 

 Pre-menopausal

399 (44)

367 (43)

766 (44)

 

 Unknown

34 (4)

34 (4)

68 (4)

 

Age at menopause (years)

   

0.22 d

 Pre/peri-menopausal

43 (5)

59 (7)

102 (6)

 

 20–43

143 (16)

151 (17)

294 (17)

 

 44–49

187 (21)

139 (16)

326 (19)

 

 50–51

191 (21)

161 (19)

352 (20)

 

 52–53

112 (12)

102 (12)

214 (12)

 

 54–55

111 (12)

119 (14)

230 (13)

 

 56–65

89 (10)

92 (11)

181 (10)

 

 Unknown

26 (3)

35 (4)

61 (3)

 

Years since onset of menopause

   

0.01d

 Pre/peri/unknown menopausal status

43 (5)

60 (7)

103 (6)

 

 0–9

190 (21)

137 (16)

327 (19)

 

 10–19

29 (32)

305 (36)

596 (34)

 

 20–29

244 (27)

196 (23)

440 (25)

 

 30–69

116 (13)

136 (16)

252 (14)

 

 Unknown

18 (2)

24 (3)

42 (2)

 

Dietary fat

   

0.55

 Low tertile

270 (30)

274 (32)

544 (31)

 

 Middle tertile

284 (31)

261 (30)

545 (31)

 

 High tertile

278 (31)

269 (31)

547 (31)

 

 Unknown

70 (8)

54 (6)

124 (7)

 

Pork consumption

   

0.01

 None

352 (39)

374 (44)

726 (41)

 

 Low (< median)

193 (21)

209 (24)

402 (23)

 

 High (> median)

287 (32)

221 (26)

508 (29)

 

 Unknown

70 (8)

54 (6)

124 (7)

 

Total red meat consumption

   

0.03

 Low tertile

252 (28)

291 (34)

543 (31)

 

 Middle tertile

279 (31)

262 (31)

541 (31)

 

 High tertile

301 (33)

25 (29)

552 (31)

 

 Unknown

70 (8)

54 (6)

124 (7)

 

Neighborhood socioeconomic status

   

0.78

 Lowest quintile

21 (2)

25 (3)

46 (3)

 

 2nd quintile

69 (8)

63 (7)

132 (8)

 

 3rd quintile

148 (16)

137 (16)

285 (16)

 

 4th quintile

260 (29)

225 (26)

485 (28)

 

 Highest quintile

331 (37)

334 (39)

665 (38)

 

 Unknown

73 (8)

74 (9)

147 (8)

 

Neighborhood urbanization

   

0.92

 Rural/Town

106 (12)

90 (10)

196 (11)

 

 City

245 (27)

230 (27)

475 (27)

 

 Suburban

440 (49)

426 (50)

866 (49)

 

 Metro

38 (4)

38 (4)

76 (4)

 

Date of blood draw

   

< 0.01

 2011 Oct-Dec

19 (2)

147 (17)

166 (9)

 

 2012 Jan-Jun

257 (28)

151 (18)

408 (23)

 

 2012 Jul-Dec

155 (17)

69 (8)

224 (13)

 

 2013 Jan-Jun

121 (13)

142 (17)

263 (15)

 

 2013 Jul-Dec

91 (10)

81 (9)

172 (10)

 

 2014 Jan-Jun

65 (7)

67 (8)

132 (8)

 

 2014 Jul-Dec

100 (11)

108 (13)

208 (12)

 

 2015 Jan-Jun

85 (9)

82 (10)

167 (9)

 

 2015 Jul-Aug

9 (1)

11 (1)

20 (1)

 

Season of blood draw

   

< 0.01

 Winter

212 (24)

300 (35)

512 (29)

 

 Spring

275 (30)

173 (20)

448 (25)

 

 Summer

242 (27)

125 (15)

367 (21)

 

 Fall

173 (19)

260 (30)

433 (25)

 
  1. aCharacteristics assessed at CTS baseline enrollment, unless otherwise noted
  2. bp-value for the Chi-square, comparing cases to controls
  3. cHT use was not characterized for pre- and peri-menopausal women
  4. dAmong postmenopausal women at blood draw